An investigation of physicians' prescribing behaviors related to antidiabetic agents for Type 2 diabetes mellitus patients and associated factors in Taiwan

Author:

Chen Xiao12,Wang Chih-Yuan3,Ko Yu14

Affiliation:

1. Department of Clinical Pharmacy, School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan

2. Department of Pharmacy, Taipei City Hospital, Taipei, Taiwan

3. Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

4. Research Center for Pharmacoeconomics, College of Pharmacy, Taipei Medical University, Taipei, Taiwan

Funder

Taiwan Tanabe Seiyaku Co. Ltd.

Publisher

Informa UK Limited

Subject

General Medicine

Reference28 articles.

1. Trends in prevalence and incidence of diabetes mellitus from 2005 to 2014 in Taiwan

2. U.S. Food and Drug Administration. Guidance for industry on diabetes mellitus-evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes; availability; 2020 [cited 2020 Dec 30]. Available from: https://www.federalregister.gov/documents/2008/12/19/E8-30086/guidance-for-industry-on-diabetes-mellitus-evaluating-cardiovascular-risk-in-new-antidiabetic

3. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

4. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3